kokphinchooi's library 66 articles Export

	Mathematical model of the cell division cycle of fission yeast [My Copy] Chaos: An Interdisciplinary Journal of Nonlinear Science, Vol. 11, No. 1. (2001), pp. 277-286. by Bela Novak, Zsuzsa Pataki, Andrea Ciliberto, John J. Tyson posted to matlab_course cell_cycle by kokphinchooi on 2009-11-25 12:31:38 as along with 1 person Dangerfc
	Kinetic Analysis of a Molecular Model of the Budding Yeast Cell Cycle [My Copy] Mol. Biol. Cell, Vol. 11, No. 1. (1 January 2000), pp. 369-391. by Katherine C. Chen, Attila Csikasz-Nagy, Bela Gyorffy, John Val, Bela Novak, John J. Tyson posted to matlab_course cell_cycle by kokphinchooi on 2009-11-24 10:46:01 as along with 3 people pjmaybank jbchang lukaswindhager
	Analysis of a generic model of eukaryotic cell-cycle regulation. [My Copy] Biophysical journal, Vol. 90, No. 12. (15 June 2006), pp. 4361-4379. by Attila Csikász-Nagy, Dorjsuren Battogtokh, Katherine C. Chen, Béla Novák, John J. Tyson posted to matlab_course cell_cycle by kokphinchooi on 2009-11-23 17:19:15 as along with 4 people bertelsen johncumbers jbchang Petersarkies
	Integrative Analysis of Cell Cycle Control in Budding Yeast [My Copy] Mol. Biol. Cell, Vol. 15, No. 8. (1 August 2004), pp. 3841-3862. by Katherine C. Chen, Laurence Calzone, Attila Csikasz-Nagy, Frederick R. Cross, Bela Novak, John J. Tyson posted to matlab_course cell_cycle by kokphinchooi on 2009-11-23 16:16:07 as along with 5 people richardfranzese dagmar monod jbchang RamuAnandakrishnan
	Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers [My Copy] Seminars in Oncology, Vol. 29, No. 1. (February 2002), pp. 27-36. by R. Herbst posted to mgcb kinases egfr cancer by kokphinchooi on 2009-11-06 05:51:20 as along with 2 people mat956 baraksch
	EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy [My Copy] Science, Vol. 304, No. 5676. (4 June 2004), pp. 1497-1500. by J. Guillermo Paez, Pasi A. Janne, Jeffrey C. Lee, et al.Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J. Kaye, Neal Lindeman, Titus J. Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J. Eck, William R. Sellers, Bruce E. Johnson, Matthew Meyerson posted to nonsmall_cell_lung_cancer mgcb kinases gefitinib egfr biological_action by kokphinchooi on 2009-11-06 05:47:51 as
	An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor [My Copy] Cell, Vol. 125, No. 6. (13 June 2006), pp. 1137-1149. by X. Zhang, J. Gureasko, K. Shen, P. Cole, J. Kuriyan posted to mgcb kinases erbb_family biological_action by kokphinchooi on 2009-11-06 05:12:47 as along with 2 people ubcg08l pjasper
	Mechanisms of specificity in protein phosphorylation [My Copy] Nature Reviews Molecular Cell Biology, Vol. 8, No. 7. (01 July 2007), pp. 530-541. by Jeffrey A. Ubersax, James E. Ferrell Jr posted to mgcb kinases general by kokphinchooi on 2009-11-05 23:44:32 as along with 6 people and 2 groups hryk coela guhjy dchughes Evangelia oelemento G4ID Genetics-of-Gambling
	The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases [My Copy] Il Farmaco, Vol. 56, No. 1-2. (1 March 2001), pp. 51-56. by W. Denny posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-04 19:14:39 as
	Review of epidermal growth factor receptor biology [My Copy] International Journal of Radiation OncologyBiologyPhysics, Vol. 59, No. 2. (June 2004), pp. S21-S26. by R. Herbst posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-04 19:13:30 as
	Tyrosine kinase inhibitors—ZD1839 (Iressa) [My Copy] Current Opinion in Oncology, Vol. 13, No. 6. (November 2001), pp. 491-498. by Carlos L. Arteaga, David H. Johnson posted to mgcb kinases gefitinib egfr convalent_inhibitor by kokphinchooi on 2009-11-04 15:36:23 as
	Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. [My Copy] Journal of Biological Chemistry, Vol. 265, No. 3. (25 January 1990), pp. 1750-1754. by G. M. Walton, W. S. Chen, M. G. Rosenfeld, G. N. Gill posted to mgcb kinases egfr by kokphinchooi on 2009-11-04 14:50:47 as
	Untangling the ErbB signalling network [My Copy] Nature Reviews Molecular Cell Biology, Vol. 2, No. 2. (01 February 2001), pp. 127-137. by Yosef Yarden, Mark X. Sliwkowski posted to mgcb kinases erbb_family cancer by kokphinchooi on 2009-11-04 14:02:27 as
	Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity [My Copy] Journal of Medicinal Chemistry, Vol. 48, No. 4. (1 February 2005), pp. 1107-1131. by Hwei-Ru Tsou, Elsebe G. Overbeek-Klumpers, William A. Hallett, et al.Marvin F. Reich, M. Brawner Floyd, Bernard D. Johnson, Ronald S. Michalak, Ramaswamy Nilakantan, Carolyn Discafani, Jonathan Golas, Sridhar K. Rabindran, Ru Shen, Xiaoqing Shi, Yu-Fen Wang, Janis Upeslacis, Allan Wissner posted to scifinder sar mgcb kinases egfr convalent_inhibitor cancer by kokphinchooi on 2009-11-04 09:45:30 as
	Emerging drugs for non-small-cell lung cancer [My Copy] Expert Opinion on Emerging Drugs, Vol. 12, No. 3. (September 2007), pp. 449-460. by Enriqueta Felip, Mariacarmela Santarpia, Rafael Rosell posted to small_cell_lung_cancer mgcb kinases by kokphinchooi on 2009-11-03 23:10:15 as
	EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. [My Copy] The New England journal of medicine, Vol. 352, No. 8. (24 February 2005), pp. 786-792. by Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, et al.Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos posted to scifinder mgcb kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 19:02:41 as along with 1 person mat956
	Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors [My Copy] Journal of Medicinal Chemistry, Vol. 49, No. 4. (1 February 2006), pp. 1475-1485. by Sylvester R. Klutchko, Hairong Zhou, R. Thomas Winters, et al.Tuan P. Tran, Alexander J. Bridges, Irene W. Althaus, Danielle M. Amato, William L. Elliott, Paul A. Ellis, Mary A. Meade, Billy J. Roberts, David W. Fry, Andrea J. Gonzales, Patricia J. Harvey, James M. Nelson, Veronica Sherwood, Hyo-Kyung Han, Gerry Pace, Jeff B. Smaill, William A. Denny, Hollis D. H. Showalter posted to scifinder mgcb egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:55:07 as
	Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies [My Copy] Cancer Res, Vol. 67, No. 21. (1 November 2007), pp. 10417-10427. by Zhiwei Yu, Titus J. Boggon, Susumu Kobayashi, et al.Cheng Jin, Patrick C. Ma, Afshin Dowlati, Jeffrey A. Kern, Daniel G. Tenen, Balazs Halmos posted to scifinder kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:52:51 as
	Dual MET\|[ndash]\|EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer [My Copy] British Journal of Cancer, Vol. 99, No. 6. (26 August 2008), pp. 911-922. by Z. Tang, R. Du, S. Jiang, et al.C. Wu, D. S. Barkauskas, J. Richey, J. Molter, M. Lam, C. Flask, S. Gerson, A. Dowlati, L. Liu, Z. Lee, B. Halmos, Y. Wang, J. A. Kern, P. C. Ma posted to scifinder mgcb kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:42:47 as
	A Differential Requirement for the COOH-terminal Region of the Epidermal Growth Factor (EGF) Receptor in Amphiregulin and EGF Mitogenic Signaling [My Copy] Journal of Biological Chemistry, Vol. 274, No. 13. (26 March 1999), pp. 8900-8909. by Lily Wong, Tushar B. Deb, Stewart A. Thompson, Alan Wells, Gibbes R. Johnson posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-03 13:00:50 as
	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies [My Copy] Cancer Cell, Vol. 9, No. 6. (13 June 2006), pp. 485-495. by Hongbin Ji, Danan Li, Liang Chen, et al.Takeshi Shimamura, Susumu Kobayashi, Kate McNamara, Umar Mahmood, Albert Mitchell, Yangping Sun, Ruqayyah Al-Hashem posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:23:58 as
	Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu) [My Copy] European Journal of Cancer, Vol. 43, No. 3. (February 2007), pp. 481-489. by A. Reid, L. Vidal, H. Shaw, J. Debono posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:22:33 as along with 1 person pjasper
	Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer [My Copy] Oncologist, Vol. 12, No. 3. (1 March 2007), pp. 325-330. by Lecia V. Sequist posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:19:10 as along with 1 person pjasper
	HKI-272 in NonâSmall Cell Lung Cancer [My Copy] Clinical Cancer Research, Vol. 13, No. 15. (1 August 2007), pp. 4593s-4596s. by Kwok-Kin Wong posted to scifinder neratinib mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-03 12:18:30 as
	The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP [My Copy] Proceedings of the National Academy of Sciences, Vol. 105, No. 6. (12 February 2008), pp. 2070-2075. by Cai-Hong Yun, Kristen E. Mengwasser, Angela V. Toms, et al.Michele S. Woo, Heidi Greulich, Kwok-Kin Wong, Matthew Meyerson, Michael J. Eck posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:09:53 as
	The Development of HKI-272 and Related Compounds for the Treatment of Cancer [My Copy] Archiv der Pharmazie, Vol. 341, No. 8. (August 2008), pp. 465-477. by Allan Wissner, Tarek S. Mansour posted to scifinder neratinib mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-03 12:03:33 as
	Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure−Activity Relationship Analysis, and Virtual Screening Studies [My Copy] Journal of Medicinal Chemistry, Vol. 52, No. 4. (26 February 2009), pp. 964-975. by Concettina La Motta, Stefania Sartini, Tiziano Tuccinardi, Erika Nerini, Federico Da Settimo, Adriano Martinelli posted to scifinder neratinib mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-03 11:56:19 as
	A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors [My Copy] Clinical Cancer Research, Vol. 15, No. 7. (1 April 2009), pp. 2552-2558. by Kwok-K Wong, Paula M. Fracasso, Ronald M. Bukowski, et al.Thomas J. Lynch, Pamela N. Munster, Geoffrey I. Shapiro, Pasi A. JÃ¤nne, Joseph P. Eder, Michael J. Naughton, Matthew J. Ellis, Suzanne F. Jones, Tarek Mekhail, Charles Zacharchuk, Jennifer Vermette, Richat Abbas, Susan Quinn, Christine Powell, Howard A. Burris posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 11:55:19 as
	Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors [My Copy] Science, Vol. 308, No. 5726. (27 May 2005), pp. 1318-1321. by Michael S. Cohen, Chao Zhang, Kevan M. Shokat, Jack Taunton posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-03 10:41:01 as along with 3 people BragilMassoud RJDReid MaggieYe
	Irreversible inhibitors of the erbB family of protein tyrosine kinases [My Copy] Pharmacology & Therapeutics, Vol. 93, No. 2-3. (March 2002), pp. 253-261. by W. Denny posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 23:05:14 as
	Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer [My Copy] Bioorganic & Medicinal Chemistry Letters, Vol. 11, No. 14. (23 July 2001), pp. 1911-1914. by A. Barker posted to mgcb kinases egfr cancer by kokphinchooi on 2009-11-02 17:38:53 as
	Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 11. (14 March 2006), pp. 4234-4239. by Andreas Schirmer, Jonathan Kennedy, Sumati Murli, Ralph Reid, Daniel V. Santi posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-02 15:16:01 as
	Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of NonâSmall Cell Lung Cancer [My Copy] Clinical Cancer Research, Vol. 12, No. 14. (15 July 2006), pp. 4441s-4445s. by John V. Heymach, Monique Nilsson, George Blumenschein, Vassiliki Papadimitrakopoulou, Roy Herbst posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:13:24 as along with 1 person pjasper
	A specific inhibitor of the epidermal growth factor receptor tyrosine kinase [My Copy] Science, Vol. 265, No. 5175. (19 August 1994), pp. 1093-1095. by D. W. Fry, A. J. Kraker, A. McMichael, et al.L. A. Ambroso, J. M. Nelson, W. R. Leopold, R. W. Connors, A. J. Bridges posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:07:10 as
	An Alternative Inhibitor Overcomes Resistance Caused by a Mutation of the Epidermal Growth Factor Receptor [My Copy] Cancer Res, Vol. 65, No. 16. (15 August 2005), pp. 7096-7101. by Susumu Kobayashi, Hongbin Ji, Yuki Yuza, et al.Matthew Meyerson, Kwok-Kin Wong, Daniel G. Tenen, Balazs Halmos posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:06:09 as along with 1 person pjasper
	Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 21. (24 May 2005), pp. 7665-7670. by Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell, et al.Nadia Godin-Heymann, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, David R. Driscoll, Panos Fidias, Thomas J. Lynch, Sridhar K. Rabindran, John P. McGinnis, Allan Wissner, Sreenath V. Sharma, Kurt J. Isselbacher, Jeffrey Settleman, Daniel A. Haber posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:04:59 as
	A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. [My Copy] Nature chemical biology, Vol. 3, No. 3. (28 March 2007), pp. 156-160. by Michael S. Cohen, Haralambos Hadjivassiliou, Jack Taunton posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-02 15:02:27 as along with 1 person guhjy
	Discovery of Selective Irreversible Inhibitors for Brutonrsquos Tyrosine Kinase [My Copy] ChemMedChem, Vol. 2, No. 1. (2007), pp. 58-61. by Zhengying Pan, Heleen Scheerens, Shyr-Jiann Li, et al.Brian E. Schultz, Paul A. Sprengeler, L. Chuck Burrill, Rohan V. Mendonca, Michael D. Sweeney, Keana C. K. Scott, Paul G. Grothaus, Douglas A. Jeffery, Jill M. Spoerke, Lee A. Honigberg, Peter R. Young, Stacie A. Dalrymple, James T. Palmer posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-02 15:01:33 as
	Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 [My Copy] Bioorganic & Medicinal Chemistry, Vol. 15, No. 11. (01 June 2007), pp. 3635-3648. by Allan Wissner, Heidi L. Fraser, Charles L. Ingalls, et al.Russell G. Dushin, M. Brawner Floyd, Kinwang Cheung, Thomas Nittoli, Malini R. Ravi, Xingzhi Tan, Frank Loganzo posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-02 15:00:59 as
	Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase [My Copy] Cancer Res, Vol. 64, No. 11. (1 June 2004), pp. 3958-3965. by Sridhar K. Rabindran, Carolyn M. Discafani, Edward C. Rosfjord, et al.Michelle Baxter, M. Brawner Floyd, Jonathan Golas, William A. Hallett, Bernard D. Johnson, Ramaswamy Nilakantan, Elsebe Overbeek, Marvin F. Reich, Ru Shen, Xiaoqing Shi, Hwei-Ru Tsou, Yu-Fen Wang, Allan Wissner posted to mgcb kinases convalent_inhibitor by kokphinchooi on 2009-11-02 14:58:10 as
	Targeting cancer with small molecule kinase inhibitors. [My Copy] Nature reviews. Cancer, Vol. 9, No. 1. (01 January 2009), pp. 28-39. by Jianming Zhang, Priscilla L. Yang, Nathanael S. Gray posted to mgcb kinases cancer by kokphinchooi on 2009-11-02 11:58:15 as along with 5 people saradtc TimRooney sschurer renatomilani guhjy
	Cell cycle kinases as therapeutic targets for cancer [My Copy] Nat Rev Drug Discov, Vol. 8, No. 7. (01 July 2009), pp. 547-566. by Silvia Lapenna, Antonio Giordano posted to mgcb kinases cancer by kokphinchooi on 2009-11-02 10:50:09 as along with 3 people guhjy sschurer reyez
	Patent Watch [My Copy] Nat Rev Drug Discov, Vol. 8, No. 11. (01 November 2009), pp. 838-839. by Charlotte Harrison posted to rock mgcb kinases cns by kokphinchooi on 2009-11-02 10:40:18 as
	Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies [My Copy] Nat Rev Drug Discov, Vol. 8, No. 10. (01 October 2009), pp. 783-793. by Kurt R. Brunden, John Q. Trojanowski, Virginia M. Y. Lee posted to mgcb kinases cns by kokphinchooi on 2009-11-02 10:36:31 as
	Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. [My Copy] Nature reviews. Drug discovery, Vol. 8, No. 9. (24 September 2009), pp. 709-723. by Pasi A. Jänne, Nathanael Gray, Jeff Settleman posted to mgcb kinases cancer by kokphinchooi on 2009-11-02 10:10:28 as along with 3 people guhjy TimRooney renatomilani
	Targeting protein kinases in central nervous system disorders [My Copy] Nature Reviews Drug Discovery, Vol. 8, No. 11. (01 November 2009), pp. 892-909. by Laura K. Chico, Linda J. Van Eldik, D. Martin Watterson posted to mgcb kinases cns by kokphinchooi on 2009-11-02 10:10:05 as along with 2 people renatomilani TimRooney
	Protein kinases \|[mdash]\| the major drug targets of the twenty-first century? [My Copy] Nat Rev Drug Discov, Vol. 1, No. 4. (01 April 2002), pp. 309-315. by Philip Cohen posted to mgcb kinases by kokphinchooi on 2009-11-02 10:09:41 as along with 2 people saradtc TimRooney
	The therapeutic potential of phosphatase inhibitors [My Copy] Current Opinion in Chemical Biology, Vol. 13, No. 3. (04 June 2009), pp. 272-283. by Viktor V. Vintonyak, Andrey P. Antonchick, Daniel Rauh, Herbert Waldmann posted to mgcb kinases by kokphinchooi on 2009-11-02 10:09:02 as along with 2 people TimRooney guhjy
	A NEW APPROACH TO DECODING LIFE: Systems Biology [My Copy] Annual Review of Genomics and Human Genetics, Vol. 2, No. 1. (2001), pp. 343-372. by Trey Ideker, Timothy Galitski, Leroy Hood posted to konrad by kokphinchooi on 2009-10-29 19:02:32 as along with 13 people and 1 group schmidtm abhishek_tiwari jaimie nedwards frohike emmackinnon okarsligil wnpx biosv mangtronix shikin lh1 cerca Bioinformatics
	Executable cell biology [My Copy] Nature Biotechnology, Vol. 25, No. 11. (07 November 2007), pp. 1239-1249. by Jasmin Fisher, Thomas A. Henzinger posted to konrad by kokphinchooi on 2009-10-29 19:01:35 as along with 18 people and 2 groups schmidtm pjmaybank daforerog dagmar Scis0000002 paulschlesinger tlse65 tmmurali austin julius dbikard neils cjeans hpaces mircea tlandrain Doug guhjy smac Centre de Recherches Interdisciplinaires

Note: You may cite this page as: http://www.citeulike.org/user/kokphinchooi

Result page: 1 2 Next

kinases	43
mgcb	43
convalent_inhibitor	25
egfr	23
scifinder	14
cancer	11
neratinib	9
molecular_genetics_and_cell_biology	8
cell_signalling	6
p70s6k	6
biological_action	5
bacterial_chemotaxis	4
cell_cycle	4
cl-387785	4
journal_club	4
konrad	4
matlab_course	4
cns	3
endomembrane	2
erbb_family	2
gefitinib	2
test	2
general	1
nonsmall_cell_lung_cancer	1
rock	1
sar	1
small_cell_lung_cancer	1

kokphinchooi's library 66 articles Export

kokphinchooi's tags